Lv1
80 积分 2024-06-29 加入
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)
6天前
已完结
Liver-targeted siRNA delivery via artificial red blood cells to lower LDL-C
6个月前
已完结
New PCSK9 inhibitor miR-552-3p reduces LDL-C via enhancing LDLR in high fat diet-fed mice
6个月前
已完结
Inclisiran as a siRNA Inhibitor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9); Past, Present, and Future
6个月前
已完结
Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies
8个月前
已完结
Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies
8个月前
已完结
Construction a novel osteoporosis model in immune-deficient mice with natural ageing
9个月前
已完结
Targeting Bruton’s tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments
1年前
已完结
BTK inhibitors enhance NKG2D ligand expression by regulating IL-10/STAT3 pathway in activated non-GCB diffuse large B-cell lymphoma cells
1年前
已完结
Discovery of a novel BTK inhibitor S-016 and identification of a new strategy for the treatment of lymphomas including BTK inhibitor-resistant lymphomas
1年前
已完结
皖公网安备34019202002308
